← All Harrow, INC filings

Harrow, INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NASDAQ
HROW
Harrow, INC
10-K: Harrow, Inc. Reports Strong Branded Growth, Strategic Pipeline Expansion
Harrow, Inc. reports significant revenue growth in its branded ophthalmic products for 2025, driven by increased marketing efforts for IHEEZO and VEVYE, alongside strategic acquisitions and debt refinancing.
NASDAQ
HROW
Harrow, INC
10-K: Harrow Inc. Appoints Amir Shojaei as Chief Scientific Officer, Bolsters Leadership Team
Harrow, Inc. extends an employment offer to Amir Shojaei to serve as Chief Scientific Officer, effective January 6, 2025, with a focus on strengthening its scientific leadership.
NASDAQ
HROW
Harrow, INC
10-K: Harrow, Inc. Details Securities and Debt in 10-K Filing
Harrow, Inc.'s 10-K filing outlines the company's registered securities, including common stock and senior notes, along with details on capital structure, anti-takeover provisions, and debt obligations.